Odisha News, Odisha Latest news, Odisha Daily - OrissaPOST
  • Home
  • Trending
  • State
  • Metro
  • National
  • International
  • Business
  • Feature
  • Entertainment
  • Sports
  • More..
    • Odisha Special
    • Editorial
    • Opinion
    • Careers
    • Sci-Tech
    • Timeout
    • Horoscope
    • Today’s Pic
  • Video
  • Epaper
  • News in Odia
  • Home
  • Trending
  • State
  • Metro
  • National
  • International
  • Business
  • Feature
  • Entertainment
  • Sports
  • More..
    • Odisha Special
    • Editorial
    • Opinion
    • Careers
    • Sci-Tech
    • Timeout
    • Horoscope
    • Today’s Pic
  • Video
  • Epaper
  • News in Odia
No Result
View All Result
OrissaPOST - Odisha Latest news, English Daily -
No Result
View All Result

Great news! COVID-19 vaccine will be ready by end of 2020; read details

IANS
Updated: July 23rd, 2020, 08:05 IST
in Coronavirus, Feature, Top Stories
0
Vaccine

photo courtesy: expresspharma.com

Share on FacebookShare on TwitterShare on WhatsAppShare on Linkedin

New York: Pfizer, which has struck a nearly $2 billion deal with the US government to deliver 100 million doses of a COVID-19 vaccine developed in collaboration with its German partner BioNTech, is hoping to seek regulatory approval for a vaccine ‘as early as October’ this year and have a vaccine on the market by year end.

A ‘best case scenario’ would be approval before year end and a vaccine by year end, according to Pfizer.

Also Read

Naveen Patnaik

Naveen Patnaik seeks Jaishankar’s help for safe return of ‘abducted’ Odisha youth from Mali

12 hours ago

Woman constable crushed to death by trailer in Rayagada district

14 hours ago

“In the third quarter of this year, we hope to get into the hospital setting with a drug that is given intravenously to patients hospitalised with COVID,” John Burkhardt, Senior Vice President, Drug Safety Research and Development at Pfizer, said at a news conference in Connecticut Wednesday.

“An interesting thing about this vaccine approach is that the mRNA is enclosed in a lipid nanoparticle, so you can imagine the complexity of that. At this site, we are looking at engineering that particle and analyses for it that will allow clinical trials as well as the manufacturing to occur,” Burkhardt said.

He promised Americans ‘safety will not be compromised’ in vaccine development. “We are very optimistic”, he said.

Americans will receive the vaccine for free and the US government can acquire up to an additional 500 million doses. Pfizer and BioNTech said in a statement they could potentially produce more than 1.3 billion doses by the end of 2021.

“Pfizer is one of the leading horses in this race right now. There may be several winners. We need several winners,” Connecticut Governor Ned Lamont said at a news conference Wednesday.

Pfizer’s Groton, Connecticut facility has a long history of drug discovery and development including Zoloft and Zithromax.

Pfizer’s vaccine candidate will now go into large scale clinical trials involving 20,000-30,000 patients before end July. It must be proven effective and receive emergency authorisation before it can be distributed.

Pfizer is finishing an earlier stage of testing to determine which of four possible candidates to try in the final study.

Preliminary data from studies have shown a good immune response from vaccinated patients, Pfizer scientists told reporters.

Pfizer and BioNTech are evaluating at least four experimental vaccines, each of which represents a unique combination of messenger RNA (mRNA) format and target antigen.

Pfizer received fast track status for two of four vaccine candidates last week based on preliminary data from ongoing Phase 1/2 studies in the United States and Germany.

Explaining the nuts and bolts of the ‘fast track’ label, Burkhardt said the new status allows straight line access to US health authorities.

“You don’t sit around and write a 100 page document, send it for review, wait 45 days for the outcome. You can be on the telephone in real time,” Burkhardt said.

Pfizer said an oral treatment for COVID-19 patients is also on its longlist.

Meanwhile, Pfizer hopes to have antiviral medication ready for clinical trials in August or September.

Also next week, a vaccine created by the National Institutes of Health and Moderna Inc. is ready to begin final-stage testing in a study of 30,000 people.

US President Donald Trump called the federal government’s $1.95 billion deal with Pfizer and biotech firm BioNTech “a historic agreement” that will help the country distribute a coronavirus vaccine in record-breaking time.

IANS

Tags: Coronaviruscovid19covid19 vaccinepandemicvaccine
ShareTweetSendShare
Suggest A Correction

Enter your email to get our daily news in your inbox.

 

OrissaPOST epaper Sunday POST OrissaPOST epaper

Click Here: Plastic Free Odisha

#MyPaperBagChallenge

Aishwarya Ranjan Mohanty

December 12, 2019
#MyPaperBagChallenge

Aman Kumar Barisal

December 12, 2019
#MyPaperBagChallenge

Subhajyoti Mohanty

December 12, 2019
#MyPaperBagChallenge

Anshuman Sahoo

December 12, 2019
#MyPaperBagChallenge

Ankita Balabantray

December 12, 2019
#MyPaperBagChallenge

Pitabas Tripathy

December 12, 2019
#MyPaperBagChallenge

Ramakanta Sahoo

December 12, 2019
#MyPaperBagChallenge

Jhili Jena

December 12, 2019
#MyPaperBagChallenge

Smitarani Sahoo

December 12, 2019
#MyPaperBagChallenge

Praptimayee Biswal

December 12, 2019
?????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????
#MyPaperBagChallenge

Dibya Ranjan Das

December 12, 2019
#MyPaperBagChallenge

Pragyan Priyambada

December 12, 2019
#MyPaperBagChallenge

Akriti Negi

December 12, 2019
#MyPaperBagChallenge

Parbati Mohanty

December 12, 2019
#MyPaperBagChallenge

Anup Mahapatra

December 12, 2019
#MyPaperBagChallenge

Akshaya Kumar Dash

December 12, 2019
#MyPaperBagChallenge

Archit Mohapatra

December 12, 2019
#MyPaperBagChallenge

Sipra Mishra

December 12, 2019
#MyPaperBagChallenge

Rajashree Manasa Mohanty

December 12, 2019
#MyPaperBagChallenge

Debasis Mohanty

December 12, 2019
#MyPaperBagChallenge

Adrita Bhattacharya

December 12, 2019
#MyPaperBagChallenge

Sisirkumar Maharana

December 12, 2019
#MyPaperBagChallenge

Amritansh Mishra

December 12, 2019
#MyPaperBagChallenge

Sibarama Khotei

December 12, 2019
#MyPaperBagChallenge

Ramakanta Sahoo

December 12, 2019
#MyPaperBagChallenge

Geetanjali Patro

December 12, 2019
#MyPaperBagChallenge

Mandakini Dakua

December 12, 2019
#MyPaperBagChallenge

Arya Ayushman

December 12, 2019
#MyPaperBagChallenge

Chinmay Kumar Routray

December 12, 2019
#MyPaperBagChallenge

Tapaswini Mallick

December 12, 2019

Archives

Editorial

India’s Spy Shift

July 5, 2025

India’s espionage architecture is quietly shifting. The appointment of Parag Jain as the new chief of RAW comes at a...

Read more

Hungary Lessons

Hungary
July 2, 2025

Revolting against oppression and seeking freedom is ingrained in human nature, something that a repressive regime finds out sooner or...

Read more

New Democratic Face

Zohran Mamdani
July 1, 2025

US President Donald Trump, who had comfortably defeated his Democratic rival Kamala Harris in the recent presidential election and exuded...

Read more

Proof To Vote

Vote
June 30, 2025

Months ahead of the Assembly polls in Bihar, the Election Commission of India (ECI) on 28 June launched a ‘special...

Read more
  • Home
  • State
  • Metro
  • National
  • International
  • Business
  • Editorial
  • Opinion
  • Sports
  • About Us
  • Advertise
  • Contact Us
  • Jobs
Developed By Ratna Technology

© 2024 All rights Reserved by OrissaPOST

  • News in Odia
  • Orissa POST Epaper
  • Video
  • Home
  • Trending
  • Metro
  • State
  • Odisha Special
  • National
  • International
  • Sports
  • Business
  • Editorial
  • Entertainment
  • Horoscope
  • Careers
  • Feature
  • Today’s Pic
  • Opinion
  • Sci-Tech
  • About Us
  • Contact Us
  • Jobs

© 2024 All rights Reserved by OrissaPOST

    • News in Odia
    • Orissa POST Epaper
    • Video
    • Home
    • Trending
    • Metro
    • State
    • Odisha Special
    • National
    • International
    • Sports
    • Business
    • Editorial
    • Entertainment
    • Horoscope
    • Careers
    • Feature
    • Today’s Pic
    • Opinion
    • Sci-Tech
    • About Us
    • Contact Us
    • Jobs

    © 2024 All rights Reserved by OrissaPOST